Diabetic Foot Ulcers, Infections Significantly Up Burden of Care

Share this content:
Diabetic Foot Ulcers, Infections Significantly Up Burden of Care
Diabetic Foot Ulcers, Infections Significantly Up Burden of Care

WEDNESDAY, May 31, 2017 (HealthDay News) -- Diabetic foot ulcers (DFUs) and diabetic foot infections (DFIs) are associated with increased risks of admission and outpatient visits, according to a study published online May 11 in Diabetes Care.

Grant H. Skrepnek, Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues conducted a cross-sectional historical cohort analysis using the nationally representative U.S. Centers for Disease Control and Prevention National Ambulatory Medical Care Survey data from 2007 to 2013. Data were included for patients age ≥18 years with diabetes and either DFIs and DFUs.

The researchers found that about 6.7 million (0.8 percent) of the estimated 5.6 billion ambulatory care visits were for DFUs and DFIs (0.3 and 0.5 percent, respectively). Relative to other ambulatory clinical cases, DFUs correlated with 3.4-fold increased odds of direct emergency department referral or inpatient admission, 2.1-fold increased odds of referral to another physician, 1.9-fold more visits in the past 12 months, and 1.4-fold longer time spend per visit with the physician, in multivariate analyses. For DFIs there were independent associations with 6.7-fold increased odds of direct emergency department referral or inpatient admission, and 1.5-fold more visits in the past 12 months.

"This investigation of an estimated 6.7 million diabetic foot cases indicates markedly greater risks for both ED/IP admissions and number of outpatient visits," the authors write.

One author disclosed financial ties to the pharmaceutical, medical device, and medical technology industries.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »